跳至主要内容
临床试验/NCT02764814
NCT02764814已完成不适用

In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye

Tissue Tech Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Short-term efficacy in terms of corneal nerve regeneration

研究概览

简要总结

Prospective controlled pilot study to compare the outcome of ProKera® (PK) and conventional treatment in patients with moderate to severe Dry Eye Disease (DED)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with moderate to severe DED (Grade 2-4 DEWS)
  • Age range: 21 years and older.
  • Both genders and all ethnic groups comparable with the local community.
  • Subjects able to understand and willing to sign a written informed consent.
  • Subjects able and willing to cooperate with investigational plan.
  • Subjects able and willing to complete postoperative follow-up.

排除标准

  • Symblepharon or lid abnormality preventing ProKera placement.
  • Ocular infection within 14 days prior to study entry.
  • Active ocular allergies.
  • Previous ocular surgery or injury within 3 months before enrollment.
  • Previous brain surgery, or Trigeminal nerve damage.
  • Other conditions that may affect corneal nerves such as diabetes, thyroid disorders.
  • Contact lens wearers.
  • Pregnancy or subject expecting to be pregnant.
  • Inability or unwillingness of subject to give written informed consent.
  • Subjects with known intolerance to PK.
  • Subjects use concomitant therapy that affects tear functions or ocular surface integrity.
  • Subjects currently engaged in another clinical trial.

结局指标

主要结局

Short-term efficacy in terms of corneal nerve regeneration

时间窗: Change from Baseline to 1 month

Assessed by corneal topography

Short-term efficacy in terms of ocular surface integrity

时间窗: Change from Baseline to 1 month

Assessed by in vivo confocal microscopy

Short-term efficacy in terms of corneal sensitivity

时间窗: Change from Baseline to 1 month

Short-term efficacy in terms of ocular clinical symptoms

时间窗: Change from Baseline to 1 month

Assessed by SPEED questionnaire, pain score, and dry eye workshop grading

次要结局

  • Long-term efficacy in terms of corneal nerve regeneration(Change from Baseline to 3 month)
  • Long-term efficacy in terms of ocular surface integrity(Change from Baseline to 3 month)
  • Long-term efficacy in terms of corneal sensitivity(Change from Baseline to 3 month)
  • Long-term efficacy in terms of ocular clinical symptoms(Change from Baseline to 3 month)

研究者

发起方
Tissue Tech Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验